CL Stock

In a June 2 research note, Haywood Capital Markets analyst Neal Gilmer reiterated a “Buy” rating... Read More

Its fourth quarter results are in the books and Roth analyst Bill Kirk still thinks there is money t... Read More

Its third quarter results are in the books and Beacon Securities analyst Russell Stanley still think... Read More

Following the company’s first quarter results, Haywood analyst Neal Gilmer has raised his pric... Read More

Following the company’s first quarter results, Echelon Capital Markets analyst Andrew Semple h... Read More

Following the company’s third quarter results, Haywood Capital Markets analyst Neal Gilmer has... Read More

The hype was enormous. Most did not live up to it. In the mid 2010’s, cannabis stocks were eve... Read More

A more modest outlook for business in Illinois and New York has Beacon Securities analyst Russell St... Read More

Haywood Capital Markets analyst Neal Gilmer is taking a more cautious outlook on Cresco Labs (Cresco... Read More

It’s still a “Hold” on US cannabis name Cresco Labs (Cresco Labs Stock Quote, Charts, News, An... Read More

The past two years have been beyond tough for cannabis stocks, but investors still have some good-lo... Read More

Beacon Securities analysts Doug Cooper and Russell Stanley provided a cannabis industry report to cl... Read More

Investors are still waiting on the proposed merger in US cannabis between Columbia Care (Columbia Ca... Read More

The US cannabis industry could be in for a “nuclear winter” over at least the first half of 2023... Read More

US cannabis stocks have edged higher in recent weeks, but the industry in general is in a bit of a h... Read More

Asdf Beacon Securities analyst Russell Stanley is still advising shareholders of US cannabis name Co... Read More

Look for third quarter revenue to be flat from US cannabis name Cresco Labs (Cresco Labs Stock Quote... Read More

Cannabis sales in the US are expected to be soft over the near term but there’s still tons of prom... Read More